Significance of m⁶A regulatory factor in gene expression and immune function of osteoarthritis

Area of Science:

• Molecular Biology
• Genetics
• Immunology

Background:

• RNA N6-methyladenosine (m⁶A) modification is a prevalent eukaryotic mRNA regulator implicated in various diseases.
• The specific role of m⁶A regulators in osteoarthritis (OA) pathogenesis remains largely unexplored.

Purpose of the Study:

• To identify key m⁶A regulators associated with osteoarthritis.
• To develop a predictive model for OA likelihood based on m⁶A regulators.
• To explore the potential of m⁶A patterns in guiding OA immunotherapies.

Main Methods:

• Differential gene expression analysis of m⁶A regulators in OA patients using the GSE48556 dataset.
• Random forest modeling to screen candidate m⁶A regulators for OA prediction.
• Consensus clustering and principal component analysis to define m⁶A patterns and scores in OA.
• Analysis of immunological responses based on m⁶A scores.

Main Results:

• Twenty-six m⁶A regulators were identified, with seven (IGFBP3, WTAP, IGFBP1, HNRNPC, RBM15B, YTHDC1, METTL3) selected as key predictors of OA.
• A predictive column line graph model for OA was developed.
• Two distinct m⁶A clusters (A and B) were identified in OA patients, with Cluster A showing higher m⁶A scores.
• Significant differences in immunological responses were observed between patients with low and high m⁶A scores.

Conclusions:

• m⁶A regulators play a significant role in the progression of osteoarthritis.
• The identified m⁶A patterns and predictive model may inform future immunotherapeutic strategies for OA.
• Further research into m⁶A modification could enhance OA treatment approaches.